Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $2.3 million.

  • Cellebrite DI's Cash from Financing Activities fell 6523.03% to $2.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $25.1 million, marking a year-over-year increase of 2131.62%. This contributed to the annual value of $25.1 million for FY2025, which is 2131.62% up from last year.
  • Cellebrite DI's Cash from Financing Activities amounted to $2.3 million in Q4 2025, which was down 6523.03% from $5.3 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Cash from Financing Activities registered a high of $13.8 million during Q2 2025, and its lowest value of -$69.5 million during Q3 2021.
  • For the 5-year period, Cellebrite DI's Cash from Financing Activities averaged around $714111.1, with its median value being $4.1 million (2022).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 43669.81% in 2023, then crashed by 6523.03% in 2025.
  • Cellebrite DI's Cash from Financing Activities (Quarter) stood at $944000.0 in 2021, then soared by 110.17% to $2.0 million in 2022, then skyrocketed by 128.33% to $4.5 million in 2023, then surged by 48.57% to $6.7 million in 2024, then plummeted by 65.23% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q4 2025, $5.3 million for Q3 2025, and $13.8 million during Q2 2025.